000504 南华生物
已收盘 09-04 15:00:00
资讯
新帖
简况
每周股票复盘：南华生物（000504）营收同比增473.56%
证券之星 · 08-30
每周股票复盘：南华生物（000504）营收同比增473.56%
南华生物（000504）披露将参加湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会，8月28日股价下跌0.12%
证券之星 · 08-28
南华生物（000504）披露将参加湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会，8月28日股价下跌0.12%
南华生物（000504）披露2026年半年度报告，8月24日股价下跌3.44%
证券之星 · 08-24
南华生物（000504）披露2026年半年度报告，8月24日股价下跌3.44%
图解南华生物中报：第二季度单季净利润同比下降303.54%
证券之星 · 08-23
图解南华生物中报：第二季度单季净利润同比下降303.54%
每周股票复盘：南华生物（000504）涨逾20%登龙虎榜
证券之星 · 07-19
每周股票复盘：南华生物（000504）涨逾20%登龙虎榜
7月16日南华生物（000504）龙虎榜数据：机构净卖出1080.69万元（3日）
证券之星 · 07-16
7月16日南华生物（000504）龙虎榜数据：机构净卖出1080.69万元（3日）
异动快报：南华生物（000504）7月16日9点39分触及涨停板
证券之星 · 07-16
异动快报：南华生物（000504）7月16日9点39分触及涨停板
每周股票复盘：南华生物（000504）上半年净利扭亏为盈
证券之星 · 07-12
每周股票复盘：南华生物（000504）上半年净利扭亏为盈
股市必读：南华生物（000504）预计2026年1-6月营业收入2.5亿元至3亿元
证券之星 · 07-10
股市必读：南华生物（000504）预计2026年1-6月营业收入2.5亿元至3亿元
南华生物（000504）披露2026年半年度业绩预告，7月9日股价上涨3.2%
证券之星 · 07-09
南华生物（000504）披露2026年半年度业绩预告，7月9日股价上涨3.2%
南华生物：第十二届董事会第十次会议决议公告
经济观察网 · 07-09
南华生物：第十二届董事会第十次会议决议公告
南华生物：预计2026年1-6月每股收益盈利:0.0127元至0.0188元
证券之星 · 07-09
南华生物：预计2026年1-6月每股收益盈利:0.0127元至0.0188元
南华生物最新公告：预计上半年净利润420万元-620万元同比扭亏
证券之星 · 07-09
南华生物最新公告：预计上半年净利润420万元-620万元同比扭亏
异动快报：*ST生物（000504）6月4日10点16分触及跌停板
证券之星 · 06-04
异动快报：*ST生物（000504）6月4日10点16分触及跌停板
股市必读：*ST生物（000504）5月29日董秘有最新回复
证券之星 · 06-01
股市必读：*ST生物（000504）5月29日董秘有最新回复
*ST生物：截至2026年3月31日公司股东人数为10,803户
证券之星 · 05-29
*ST生物：截至2026年3月31日公司股东人数为10,803户
每周股票复盘：*ST生物（000504）申请撤销退市风险警示进展公布
证券之星 · 05-24
每周股票复盘：*ST生物（000504）申请撤销退市风险警示进展公布
*ST生物（000504）披露申请撤销退市风险警示进展公告，5月21日股价下跌1.18%
证券之星 · 05-21
*ST生物（000504）披露申请撤销退市风险警示进展公告，5月21日股价下跌1.18%
每周股票复盘：*ST生物（000504）一季度净利增600%
证券之星 · 05-02
每周股票复盘：*ST生物（000504）一季度净利增600%
*ST生物(000504)3月31日股东户数1.08万户，较上期减少9.06%
证券之星 · 04-29
*ST生物(000504)3月31日股东户数1.08万户，较上期减少9.06%
暂无数据
公司概况
公司名称：
南华生物医药股份有限公司
所属行业：
科技推广和应用服务业
上市日期：
1992-12-08
主营业务：
南华生物医药股份有限公司的主营业务是人源细胞等检测、存储保管等服务；美妆净化器销售以及碳酸锂生产与销售、废钢加工与销售业务。公司的主要产品是细胞储存技术服务、生物医药相关产品销售、碳酸锂业务、废钢再生资源业务。
发行价格：
1.00
{"stockData":{"symbol":"000504","market":"SZ","secType":"STK","nameCN":"南华生物","latestPrice":8.1,"timestamp":1788505428000,"preClose":8.12,"halted":0,"volume":3389700,"delay":0,"changeRate":-0.0025,"floatShares":329000000,"shares":330000000,"eps":0.1161,"marketStatus":"已收盘","change":-0.02,"latestTime":"09-04 15:00:00","open":8.2,"high":8.27,"low":8.07,"amount":27746000,"amplitude":0.0246,"askPrice":8.11,"askSize":4,"bidPrice":8.1,"bidSize":109,"shortable":0,"etf":0,"ttmEps":0.1161,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":8.12,"symbolType":"stock","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":8.93,"lowLimit":7.31,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":330023098,"isCdr":false,"pbRate":9.86,"roa":"--","peRate":69.767442,"roe":"2.23%","epsLYR":0.09,"committee":0.137849,"marketValue":2673000000,"turnoverRate":0.0103,"status":1,"floatMarketCap":2666000000},"requestUrl":"/m/hq/s/000504/tweets","defaultTab":"tweets","newsList":[{"id":"2663043159","title":"每周股票复盘：南华生物（000504）营收同比增473.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043159","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663043159?lang=zh_cn&edition=full","pubTime":"2026-08-30 08:00","pubTimestamp":1788048046,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，南华生物报收于8.4元，较上周的8.43元下跌0.36%。业绩披露要点南华生物2026年半年度报告显示，本报告期营业收入为295,914,290.97元，上年同期为51,592,126.65元，同比增长473.56%。本报告期末总资产为881,233,019.40元，上年度末为991,731,003.76元，同比下降11.14%。归属于上市公司股东的净资产为271,743,864.95元，上年度末为265,751,170.73元，同比增长2.26%。报告期控股股东和实际控制人均未发生变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662968091","title":"南华生物（000504）披露将参加湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会，8月28日股价下跌0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662968091","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662968091?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:34","pubTimestamp":1787927681,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，南华生物报收于8.4元，较前一交易日下跌0.12%，最新总市值为27.72亿元。该股当日开盘8.41元，最高8.48元，最低8.22元，成交额达3594.76万元，换手率为1.31%。近日，南华生物医药股份有限公司披露《关于参加2026年湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会活动的公告》。公司高管将在活动中就2025年至2026半年度业绩、公司治理、发展战略、经营状况和可持续发展等话题与投资者进行交流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800055215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0282","BK0042","000504","BK0086","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661014220","title":"南华生物（000504）披露2026年半年度报告，8月24日股价下跌3.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661014220","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661014220?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:19","pubTimestamp":1787566757,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，南华生物报收于8.14元，较前一交易日下跌3.44%，最新总市值为26.86亿元。该股当日开盘8.43元，最高8.53元，最低8.08元，成交额达3534.64万元，换手率为1.31%。南华生物于2026年8月24日披露《2026年半年度报告》。报告显示，本报告期营业收入为295,914,290.97元，上年同期为51,592,126.65元，同比增长473.56%。本报告期末总资产为881,233,019.40元，上年度末为991,731,003.76元，同比下降11.14%。报告期控股股东和实际控制人均未发生变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0046","BK0042","BK0282","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661716210","title":"图解南华生物中报：第二季度单季净利润同比下降303.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661716210","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661716210?lang=zh_cn&edition=full","pubTime":"2026-08-23 17:16","pubTimestamp":1787476611,"startTime":"0","endTime":"0","summary":"证券之星消息，南华生物2026年中报显示，上半年度公司主营收入2.96亿元，同比上升473.56%；归母净利润599.27万元，同比上升271.99%；扣非净利润431.7万元，同比上升164.86%；其中2026年第二季度，公司单季度主营收入1.77亿元，同比上升506.11%；单季度归母净利润-510.8万元，同比下降303.54%；单季度扣非净利润-602.08万元，同比下降88.19%；负债率59.28%，投资收益152.41万元，财务费用401.34万元，毛利率10.01%。财报数据概要请见下图:本文数据来源于南华生物2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300008362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230112","title":"每周股票复盘：南华生物（000504）涨逾20%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230112?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:45","pubTimestamp":1784400310,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，南华生物报收于8.55元，较上周的8.06元上涨6.08%。本周，南华生物7月16日盘中最高价报9.36元。交易信息汇总龙虎榜上榜沪深交易所2026年7月16日公布的交易公开信息显示，南华生物因连续三个交易日内涨幅偏离值累计达到20%登上龙虎榜。公司公告汇总南华生物股票交易异常波动的公告南华生物股票于2026年7月15日、7月16日连续两个交易日收盘价格涨幅累计偏离超过20%，构成异常波动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0282","BK0086","000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651410260","title":"7月16日南华生物（000504）龙虎榜数据：机构净卖出1080.69万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2651410260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651410260?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:22","pubTimestamp":1784193747,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月16日公布的交易公开信息显示，南华生物因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月16日收盘，南华生物报收于9.36元，上涨9.99%，已连续涨停2天，换手率8.73%，成交量28.74万手，成交额2.65亿元。从龙虎榜公布的三日买卖数据来看，机构合计净卖出1080.69万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600028157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","000504","BK0282","BK0042","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651497563","title":"异动快报：南华生物（000504）7月16日9点39分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651497563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651497563?lang=zh_cn&edition=full","pubTime":"2026-07-16 09:41","pubTimestamp":1784166072,"startTime":"0","endTime":"0","summary":"证券之星7月16日盘中消息，9点39分南华生物（000504）触及涨停板。其所属行业医疗服务目前下跌。领涨股为昭衍新药。该股为污水处理，湖南国企改革，环保概念热股。7月15日的资金流向数据方面，主力资金净流入3376.1万元，占总成交额32.37%，游资资金净流出2291.27万元，占总成交额21.97%，散户资金净流出1084.83万元，占总成交额10.4%。近5日资金流向一览见下表：南华生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600008198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","000504","BK0046","BK0282"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650672154","title":"每周股票复盘：南华生物（000504）上半年净利扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2650672154","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650672154?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:25","pubTimestamp":1783794312,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，南华生物报收于8.06元，较上周的7.98元上涨1.0%。本周关注点来自业绩披露要点：南华生物预计2026年上半年归属净利润盈利420万元至620万元，实现扭亏为盈。公司公告汇总2026-037 南华生物2026年半年度业绩预告的公告南华生物预计2026年上半年营收25,000万元至30,000万元，同比增长384.57%至481.48%；归母净利润盈利420万元至620万元，扭亏为盈，上年同期亏损348.44万元；扣非后净利润盈利350万元至450万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0046","BK0282","BK0086","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650017976","title":"股市必读：南华生物（000504）预计2026年1-6月营业收入2.5亿元至3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650017976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650017976?lang=zh_cn&edition=full","pubTime":"2026-07-10 01:55","pubTimestamp":1783619712,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，南华生物报收于8.07元，上涨3.2%，换手率2.8%，成交量9.21万手，成交额7521.32万元。业绩披露要点业绩预告预计2026年1–6月每股收益盈利0.0127元至0.0188元；归属净利润盈利420万元至620万元；扣非后净利润盈利350万元至450万元；营业收入2.5亿元至3亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000001098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650200129","title":"南华生物（000504）披露2026年半年度业绩预告，7月9日股价上涨3.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650200129","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650200129?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:32","pubTimestamp":1783607532,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，南华生物报收于8.07元，较前一交易日上涨3.2%，最新总市值为26.63亿元。近日，南华生物医药股份有限公司披露《2026年半年度业绩预告》。公告显示，公司预计2026年上半年实现营业收入25,000万元至30,000万元，同比增长384.57%至481.48%；归属于上市公司股东的净利润为盈利420万元至620万元，实现扭亏为盈。本次业绩预告未经会计师事务所预审计，具体财务数据以2026年半年度报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900042672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0282","000504","BK0086","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650978664","title":"南华生物：第十二届董事会第十次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2650978664","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650978664?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:23","pubTimestamp":1783606980,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网讯 7月9日，南华生物发布公告称，公司第十二届董事会第十次会议审议通过《关于修订〈信息披露事务管理制度〉的议案》等多项议案。（编辑 姚尧）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-07-09/doc-inihfpqu4271311.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-07-09/doc-inihfpqu4271311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000504","BK0042","BK0046","BK0086","BK0282"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650392153","title":"南华生物：预计2026年1-6月每股收益盈利:0.0127元至0.0188元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650392153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650392153?lang=zh_cn&edition=full","pubTime":"2026-07-09 20:00","pubTimestamp":1783598444,"startTime":"0","endTime":"0","summary":"证券之星消息，南华生物发布业绩预告，预计2026年1-6月每股收益盈利:0.0127元至0.0188元。南华生物2026年一季报显示，一季度公司主营收入1.19亿元，同比上升431.32%；归母净利润1110.07万元，同比上升600.34%；扣非净利润1033.78万元，同比上升399.05%；负债率63.69%，投资收益49.87万元，财务费用231.91万元，毛利率20.46%。本文数据来源于《南华生物:2026-037南华生物2026年半年度业绩预告的公告》，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900038370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0086","000504","BK0282","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650692637","title":"南华生物最新公告：预计上半年净利润420万元-620万元同比扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2650692637","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650692637?lang=zh_cn&edition=full","pubTime":"2026-07-09 19:01","pubTimestamp":1783594908,"startTime":"0","endTime":"0","summary":"南华生物(000504.SZ)公告称，预计2026年上半年归母净利润为420万元-620万元，去年同期亏损348.44万元，同比扭亏为盈。报告期内，受益于碳酸锂及再生资源业务的开展，与上年同期相比，公司收入规模有较大幅度提升。注：公司Q2净利润预计亏损0.05亿-亏损0.07亿，Q1净利润0.11亿，据此计算，Q2净利润预计环比由盈转亏。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900035503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640013633","title":"异动快报：*ST生物（000504）6月4日10点16分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2640013633","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640013633?lang=zh_cn&edition=full","pubTime":"2026-06-04 10:25","pubTimestamp":1780539950,"startTime":"0","endTime":"0","summary":"证券之星6月4日盘中消息，10点16分*ST生物（000504）触及跌停板。其所属行业医疗服务目前下跌。领涨股为百诚医药。该股为污水处理，环保，国企改革概念热股。6月3日的资金流向数据方面，主力资金净流出408.82万元，占总成交额12.9%，游资资金净流入347.32万元，占总成交额10.96%，散户资金净流入61.51万元，占总成交额1.94%。近5日资金流向一览见下表：*ST生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400010250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","000504","BK0086","BK0042","BK0282"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640855409","title":"股市必读：*ST生物（000504）5月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640855409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640855409?lang=zh_cn&edition=full","pubTime":"2026-06-01 03:12","pubTimestamp":1780254734,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，*ST生物报收于9.46元，下跌2.07%，换手率1.11%，成交量3.65万手，成交额3480.04万元。董秘最新回复投资者： 董秘您好，关注到公司2025年收购娄底金弘新材料后，再生资源、锂电回收业务营收占比已大幅提升，远超原有生物医药板块，目前主营业务结构已发生明显变化。截至2026年3月31日公司股东人数为10,803户，相关数据请查阅公司定期报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100001359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0282","BK0042","000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639652620","title":"*ST生物：截至2026年3月31日公司股东人数为10,803户","url":"https://stock-news.laohu8.com/highlight/detail?id=2639652620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2639652620?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:53","pubTimestamp":1780059194,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST生物(000504)05月29日在投资者关系平台上答复投资者关心的问题。投资者提问：5月20日股东人数多少？*ST生物回复：尊敬的投资者，您好！截至2026年3月31日公司股东人数为10,803户，相关数据请查阅公司定期报告。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900043580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0042","BK0282","BK0046","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637375946","title":"每周股票复盘：*ST生物（000504）申请撤销退市风险警示进展公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2637375946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637375946?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:36","pubTimestamp":1779564973,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，*ST生物报收于9.49元，较上周的9.26元上涨2.48%。本周，*ST生物5月21日盘中最高价报9.5元。本周关注点公司公告汇总：*ST生物申请撤销退市风险警示，目前处于补充材料阶段。出席股东共111名，代表股份占公司总股本的42.2620%。南华生物关于申请撤销退市风险警示的进展公告指出，公司于2026年4月28日向深圳证券交易所提交撤销退市风险警示申请，截至2026年5月22日，该申请处于补充材料阶段，能否获批存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0042","BK0046","000504","BK0282"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382260","title":"*ST生物（000504）披露申请撤销退市风险警示进展公告，5月21日股价下跌1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637382260?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:32","pubTimestamp":1779359535,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，*ST生物报收于9.25元，较前一交易日下跌1.18%，最新总市值为30.53亿元。该股当日开盘9.38元，最高9.5元，最低9.2元，成交额达3664.1万元，换手率为1.19%。近日，*ST生物发布《关于申请撤销退市风险警示的进展公告》。公告显示，公司于2026年4月28日向深圳证券交易所提交了撤销退市风险警示的申请，相关公告已于2026年4月29日披露。截至公告披露日，该申请处于补充材料阶段，能否获批存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","BK0046","BK0282","000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632092647","title":"每周股票复盘：*ST生物（000504）一季度净利增600%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632092647","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632092647?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:33","pubTimestamp":1777667589,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，*ST生物报收于9.18元，较上周的9.9元下跌7.27%。本周，*ST生物4月27日盘中最高价报10.28元。业绩披露要点：*ST生物2026年一季报显示，归母净利润1110.07万元，同比上升600.34%。公司公告汇总：*ST生物因2024年度多项财务指标不达标，股票已被实施退市风险警示。股本股东变化股东户数变动截至2026年3月31日，*ST生物股东户数为1.08万户，较2025年12月31日减少1076.0户，减幅为9.06%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0046","BK0042","BK0282","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631964995","title":"*ST生物(000504)3月31日股东户数1.08万户，较上期减少9.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631964995","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631964995?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:46","pubTimestamp":1777455960,"startTime":"0","endTime":"0","summary":"证券之星消息，近日*ST生物披露，截至2026年3月31日公司股东户数为1.08万户，较12月31日减少1076.0户，减幅为9.06%。在医疗服务行业个股中，*ST生物股东户数低于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.91万户。从股价来看，2025年12月31日至2026年3月31日，*ST生物区间涨幅为12.4%，在此期间股东户数减少1076.0户，减幅为9.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0282","BK0046","BK0086","000504"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788727672165,"stockEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0012},{"period":"3month","weight":-0.0493},{"period":"6month","weight":-0.104},{"period":"1year","weight":-0.1215},{"period":"ytd","weight":-0.095}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南华生物医药股份有限公司","boardCode":"AI0075","boardName":"科技推广和应用服务业","stockholders":"13284人(较上一季度增加22.97%)","perCapita":"24775股","listingDate":"1992-12-08","address":"湖南省长沙市岳麓区高新区岳麓西大道1698号麓谷科技创新创业园B1栋3楼","registeredCapital":"33002万元","survey":" 南华生物医药股份有限公司的主营业务是人源细胞等检测、存储保管等服务；美妆净化器销售以及碳酸锂生产与销售、废钢加工与销售业务。公司的主要产品是细胞储存技术服务、生物医药相关产品销售、碳酸锂业务、废钢再生资源业务。","listedPrice":1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南华生物(000504)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南华生物(000504)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南华生物,000504,南华生物股票,南华生物股票老虎,南华生物股票老虎国际,南华生物行情,南华生物股票行情,南华生物股价,南华生物股市,南华生物股票价格,南华生物股票交易,南华生物股票购买,南华生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南华生物(000504)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南华生物(000504)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}